Eli Lilly (LLY) Cash from Operations (2009 - 2026)
Eli Lilly (LLY) posted Cash from Operations of $11.4 billion for Q3 2026, up 29.0% from $8.84 billion a year earlier and up 6.6% from the prior quarter.
Eli Lilly (LLY) Cash from Operations (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Cash from Operations at Eli Lilly was $30.65 billion, up 90.8% year-over-year; for FY2025, it came in at $16.81 billion, up 90.7% from FY2024.
- Annual Cash from Operations shows a five-year compound annual growth rate of 20.9% (FY2020 to FY2025).
- In prior years, Eli Lilly's Cash from Operations was $8.82 billion in FY2024 (+108.0%), $4.24 billion in FY2023 (-44.1%), $7.59 billion in FY2022 (+3.0%) and $7.37 billion in FY2021 (+13.3%).
- The Q3 2026 figure stands as the highest quarterly Cash from Operations in data going back to Q1 2009.
- On a year-over-year basis, Cash from Operations has increased in each of the last seven quarters, with growth averaging 116.7% over the last seven quarters.
- The strongest year-over-year quarter for Cash from Operations in the past five years was Q2 2026, with growth of 246.3%; the weakest was Q2 2023, with a decline of 46.6%.
- According to Business Quant data, Cash from Operations for the three prior quarters was $10.69 billion (Q2 2026), $5.33 billion (Q1 2026) and $3.23 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 11.40 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 7.72 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.61 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 6.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.67 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.24 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.38 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 643.10 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.40 Bn |
| Jun 30, 2026 | 10.69 Bn |
| Mar 31, 2026 | 5.33 Bn |
| Dec 31, 2025 | 3.23 Bn |
| Sep 30, 2025 | 8.84 Bn |
| Jun 30, 2025 | 3.09 Bn |
| Mar 31, 2025 | 1.67 Bn |
| Dec 31, 2024 | 2.47 Bn |
| Sep 30, 2024 | 3.71 Bn |
| Jun 30, 2024 | 1.47 Bn |
| Mar 31, 2024 | 1.17 Bn |
| Dec 31, 2023 | -312.00 Mn |
| Sep 30, 2023 | 2.19 Bn |
| Jun 30, 2023 | 631.90 Mn |
| Mar 31, 2023 | 1.73 Bn |
| Dec 31, 2022 | 1.66 Bn |
| Sep 30, 2022 | 2.22 Bn |
| Jun 30, 2022 | 1.18 Bn |
| Mar 31, 2022 | 2.52 Bn |
| Dec 31, 2021 | 2.26 Bn |
Eli Lilly Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=LLY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();